BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8111439)

  • 1. Drug therapy management of the febrile neutropenic cancer patient.
    Finkbiner KL; Ernst TF
    Cancer Pract; 1993; 1(4):295-304. PubMed ID: 8111439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of febrile neutropenia and neutropenic infections in elderly patients receiving anthracycline-based chemotherapy for breast cancer without primary prophylaxis with colony-stimulating factors.
    Minisini A; Spazzapan S; Crivellari D; Aapro M; Biganzoli L
    Crit Rev Oncol Hematol; 2005 Feb; 53(2):125-31. PubMed ID: 15661563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Febrile neutropenia in haematological malignancies.
    Sharma A; Lokeshwar N
    J Postgrad Med; 2005; 51 Suppl 1():S42-8. PubMed ID: 16519255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of chemotherapy-induced neutropenic fever.
    Bhardwaj AS; Navada SC
    Hosp Pract (1995); 2013 Feb; 41(1):96-108. PubMed ID: 23466972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.
    Clark OA; Lyman GH; Castro AA; Clark LG; Djulbegovic B
    J Clin Oncol; 2005 Jun; 23(18):4198-214. PubMed ID: 15961767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.
    Hughes WT; Armstrong D; Bodey GP; Bow EJ; Brown AE; Calandra T; Feld R; Pizzo PA; Rolston KV; Shenep JL; Young LS
    Clin Infect Dis; 2002 Mar; 34(6):730-51. PubMed ID: 11850858
    [No Abstract]   [Full Text] [Related]  

  • 7. Fever and neutropenia in pediatric patients with cancer.
    Meckler G; Lindemulder S
    Emerg Med Clin North Am; 2009 Aug; 27(3):525-44. PubMed ID: 19646652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of colony-stimulating factors for chemotherapy-associated neutropenia: review of current guidelines.
    Heuser M; Ganser A; Bokemeyer C; ; ;
    Semin Hematol; 2007 Jul; 44(3):148-56. PubMed ID: 17631179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Empirical treatment of fever and neutropenia: rationalization of antimicrobial schemes in the patient with cancer].
    Santos JI
    Bol Med Hosp Infant Mex; 1989 Dec; 46(12):759-60. PubMed ID: 2627270
    [No Abstract]   [Full Text] [Related]  

  • 10. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economics of the colony-stimulating factors in the prevention and treatment of febrile neutropenia.
    Lyman GH; Kuderer NM
    Crit Rev Oncol Hematol; 2004 May; 50(2):129-46. PubMed ID: 15157662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Febrile neutropenia].
    Tamura K
    Rinsho Ketsueki; 2007 Apr; 48(4):273-84. PubMed ID: 17515117
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of the cancer patient with infection and neutropenia.
    Rapoport BL
    Semin Oncol; 2011 Jun; 38(3):424-30. PubMed ID: 21600373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infection in the cancer patient. The management of neutropenic fever].
    Provencio M; López-Vega JM; Bonilla F; España P
    An Med Interna; 1993 Mar; 10(3):143-6. PubMed ID: 8485286
    [No Abstract]   [Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factors: finding the right indication.
    Lyman GH; Shayne M
    Curr Opin Oncol; 2007 Jul; 19(4):299-307. PubMed ID: 17545791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical antimicrobial treatment for chemotherapy-induced febrile neutropenia.
    Bal AM; Gould IM
    Int J Antimicrob Agents; 2007 May; 29(5):501-9. PubMed ID: 17346939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral antibiotics for febrile patients with neutropenia due to cancer chemotherapy.
    Lishner M
    N Engl J Med; 2000 Jan; 342(1):55-6; author reply 56-8. PubMed ID: 10627210
    [No Abstract]   [Full Text] [Related]  

  • 18. Empirical and subsequent use of antibacterial agents in the febrile neutropenic patient.
    De Pauw BE; Raemaekers JM; Schattenberg T; Donnelly JP
    J Intern Med Suppl; 1997; 740():69-77. PubMed ID: 9350186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
    Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Febrile neutropenia].
    Masaoka T
    Ryoikibetsu Shokogun Shirizu; 2000; (32):451-3. PubMed ID: 11212772
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.